Boston Healthcare & DII announce life sciences data partnership

Life sciences consultancy Boston Healthcare and market research institute Data Information Intelligence (DII) GmbH have announced a partnership aimed at commercialising life sciences data and analytics for biopharmaceutical, medical device and diagnostic companies.

The companies’ joint offering will provide clients across Europe, the Middle East and North and South America with data and analytics. Clients will have access to data from over 7,000 hospitals and labs including detailed insights on installations from over 2,400 hospitals and labs and clinical diagnostics testing volumes, trends, systems, and reagents used for molecular and IVD tests in over 1,500 labs.

Joseph Ferrara, president of Boston Healthcare said: “We are excited to announce this new agreement with (DII), which will not only expand our global market analytics offering, but more importantly will deliver highly granular insight into how diagnostic tools are adopted by treating clinicians and laboratories globally.”

Kathrin Franke, managing director of DII said: “Our research institute aggregates and analyses a unique and centralised dataset that provides a comprehensive understanding of key country-specific life science market dynamics and clinical practice approaches. This level of analysis leads to deep comparative insights across key global markets.”